Free Trial

BioCryst Pharmaceuticals (BCRX) Earnings Date, Estimates & Call Transcripts

$6.13
-0.20 (-3.16%)
(As of 05/24/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 6)
-$0.17 Beat By $0.06
Consensus EPS
(May. 6)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

BCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioCryst Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.19)($0.19)($0.19)
Q2 20241($0.14)($0.14)($0.14)
Q3 20241($0.10)($0.10)($0.10)
Q4 20241($0.09)($0.09)($0.09)
FY 20244($0.52)($0.52)($0.52)

BCRX Earnings Date and Information

BioCryst Pharmaceuticals last posted its earnings results on May 6th, 2024. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.06. The firm had revenue of $92.80 million for the quarter, compared to analyst estimates of $85.62 million. Its revenue for the quarter was up 34.9% on a year-over-year basis. BioCryst Pharmaceuticals has generated ($1.07) earnings per share over the last year (($1.07) diluted earnings per share). Earnings for BioCryst Pharmaceuticals are expected to grow in the coming year, from ($0.66) to ($0.28) per share. BioCryst Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

BioCryst Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/6/2024Q1 2024($0.23)($0.17)+$0.06($0.17)$85.62 million$92.80 million    
2/26/2024Q4 2023($0.24)($0.28)($0.04)($0.25)$89.19 million$93.40 million
11/2/2023Q3 2023($0.25)($0.19)+$0.06($0.19)$86.54 million$86.74 million
8/3/2023Q2 2023($0.25)($0.24)+$0.01($0.08)$81.42 million$81.01 million    
5/3/2023Q1 2023($0.30)($0.28)+$0.02($0.28)$71.44 million$68.80 million    
2/21/2023Q4 2022($0.19)($0.38)($0.19)($0.38)$74.18 million$79.50 million    
11/1/2022Q3 2022($0.32)($0.23)+$0.09($0.23)$73.45 million$75.83 million
8/4/2022Q2 2022($0.36)($0.32)+$0.04($0.32)$63.92 million$65.53 million    
5/5/2022Q1 2022($0.39)($0.40)($0.01)($0.40)$50.59 million$49.92 million
2/23/2022Q4 2021($0.31)($0.40)($0.09)($0.70)$48.18 million$47.16 million
11/2/2021Q3 2021($0.29)($0.33)($0.04)($0.33)$37.75 million$40.99 million    
8/5/2021Q2 2021($0.22)($0.24)($0.02)($0.24)$31.37 million$49.96 million    
5/6/2021Q1 2021($0.26)($0.36)($0.10)($0.36)$12.80 million$19.06 million  
2/24/2021Q4 2020($0.25)($0.34)($0.09)($0.34)$14.72 million$4.02 million  
11/5/2020Q3 2020($0.25)($0.26)($0.01)($0.26)$4.31 million$6.10 million  
8/6/2020Q2 2020($0.28)($0.24)+$0.04($0.24)$3.17 million$2.87 million  
5/6/2020Q1 2020($0.24)($0.24)-($0.24)$2.71 million$4.82 million  
3/5/2020Q4 2019($0.26)($0.02)+$0.24($0.02)$12.02 million$39.73 million  
11/6/2019Q3($0.31)($0.34)($0.03)($0.34)$4.54 million$1.78 million  
8/6/2019Q2 2019($0.31)($0.34)($0.03)($0.34)$2.52 million$1.45 million

BioCryst Pharmaceuticals Earnings - Frequently Asked Questions

When is BioCryst Pharmaceuticals's earnings date?

BioCryst Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on BCRX's earnings history.

Did BioCryst Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.06. Learn more on analysts' earnings estimate vs. BCRX's actual earnings.

How can I listen to BioCryst Pharmaceuticals's earnings conference call?

The conference call for BioCryst Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read BioCryst Pharmaceuticals's conference call transcript?

The conference call transcript for BioCryst Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does BioCryst Pharmaceuticals generate each year?

BioCryst Pharmaceuticals (NASDAQ:BCRX) has a recorded annual revenue of $331.41 million.

How much profit does BioCryst Pharmaceuticals generate each year?

BioCryst Pharmaceuticals (NASDAQ:BCRX) has a recorded net income of -$226.54 million. BCRX has generated -$1.07 earnings per share over the last four quarters.

What is BioCryst Pharmaceuticals's EPS forecast for next year?

BioCryst Pharmaceuticals's earnings are expected to grow from ($0.66) per share to ($0.28) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BCRX) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners